Tenax Therapeutics Inc (TENX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $11.75
• Market Cap: $77.30M
• EPS: $-0.74
• 52-Week High: $18.38
• 52-Week Low: $4.63

Market Sentiment

Tenax Therapeutics Inc currently has a Bullish sentiment score of 0.45.

About Tenax Therapeutics Inc

Tenax Therapeutics, Inc. is a specialty pharmaceutical company based in Morrisville, North Carolina, dedicated to developing innovative therapies for cardiovascular and pulmonary diseases in the U.S. and Canadian markets. The company focuses on addressing significant unmet medical needs through its proprietary drug development pipeline, highlighting products designed to enhance patient outcomes in critical care environments. With a strong commitment to advancing treatment options in these vit...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Tenax Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TENX pay dividends?

Tenax Therapeutics Inc (TENX) does not currently pay a regular dividend.

What is TENX's market cap?

Tenax Therapeutics Inc (TENX) has a market capitalization of $77.30M with a current stock price of $11.75.